Association of human

Cancer Polymorphism Susceptibility XPA

Journal

Cancer cell international

ISSN: 1475-2867

Titre abrégé: Cancer Cell Int

Pays: England

ID NLM: 101139795

Informations de publication

Date de publication:
2020

Historique:

received: 03 06 2019

accepted: 07 05 2020

entrez: 22 5 2020

pubmed: 22 5 2020

medline: 22 5 2020

Statut: epublish

Résumé

The objective of the present study is to comprehensively evaluate the impact of the rs1800975 A/G polymorphism within the human xeroderma pigmentosum group A ( We retrieved possible relevant publications from a total of six electronic databases (updated to April 2020) and selected eligible case-control studies for pooled assessment. In total, 71 case-control studies with 19,257 cases and 30,208 controls from 52 publications were included for pooling analysis. We observed an enhanced overall cancer susceptibility in cancer cases compared with negative controls in the Caucasian subgroup analysis for the genetic models of allelic G vs. A, carrier G vs. A, homozygotic GG vs AA, heterozygotic AG vs. AA, dominant AG + GG vs. AA and recessive GG vs. AA + AG ( Our findings provide evidence of the close relationship between the

Sections du résumé

BACKGROUND BACKGROUND

The objective of the present study is to comprehensively evaluate the impact of the rs1800975 A/G polymorphism within the human xeroderma pigmentosum group A (

METHODS METHODS

We retrieved possible relevant publications from a total of six electronic databases (updated to April 2020) and selected eligible case-control studies for pooled assessment.

RESULTS RESULTS

In total, 71 case-control studies with 19,257 cases and 30,208 controls from 52 publications were included for pooling analysis. We observed an enhanced overall cancer susceptibility in cancer cases compared with negative controls in the Caucasian subgroup analysis for the genetic models of allelic G vs. A, carrier G vs. A, homozygotic GG vs AA, heterozygotic AG vs. AA, dominant AG + GG vs. AA and recessive GG vs. AA + AG (

CONCLUSIONS CONCLUSIONS

Our findings provide evidence of the close relationship between the

Identifiants

DOI: 10.1186/s12935-020-01244-5 PMID: 32435155 PMC: PMC7218628

pubmed: 32435155

doi: 10.1186/s12935-020-01244-5

pii: 1244

pmc: PMC7218628

doi:

Types de publication

Journal Article

Langues

eng

Pagination

164

Informations de copyright

Déclaration de conflit d'intérêts

Competing interestsThe authors declare that they have no competing interests.

Références

Comput Struct Biotechnol J. 2015 Dec 08;14:78-85

pubmed: 26865925

Chin J Physiol. 2007 Dec 31;50(6):294-300

pubmed: 18442012

Cancer Epidemiol Biomarkers Prev. 2002 Oct;11(10 Pt 1):993-7

pubmed: 12376498

Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Sep;29(9):930-3

pubmed: 19173862

DNA Repair (Amst). 2016 Aug;44:123-135

pubmed: 27247238

Int J Dermatol. 2014 Dec;53(12):1474-7

pubmed: 25209577

J Clin Gastroenterol. 2008 Sep;42(8):910-5

pubmed: 18645534

J Appl Genet. 2010;51(3):343-52

pubmed: 20720310

Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1873-82

pubmed: 21750170

Int J Cancer. 2009 Sep 15;125(6):1431-9

pubmed: 19444904

Onco Targets Ther. 2015 Feb 05;8:385-94

pubmed: 25709470

J Biomol Struct Dyn. 2019 Aug;37(13):3322-3336

pubmed: 30205752

Mutat Res. 2019 Nov;816-818:111673

pubmed: 31195348

J Natl Cancer Inst. 2004 Mar 17;96(6):434-42

pubmed: 15026468

Mol Ther Nucleic Acids. 2018 Sep 7;12:854-860

pubmed: 30161024

Carcinogenesis. 2006 Aug;27(8):1670-5

pubmed: 16513681

PLoS Med. 2009 Jul 21;6(7):e1000097

pubmed: 19621072

Cancer Res. 2017 Nov 1;77(21):e108-e110

pubmed: 29092952

Int J Cancer. 2013 Sep 1;133(5):1094-100

pubmed: 23436679

Mutat Res. 2007 Jul 28;631(2):101-10

pubmed: 17531525

Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1614-9

pubmed: 16985021

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2242-6

pubmed: 15598786

Mol Carcinog. 2013 Nov;52 Suppl 1:E70-9

pubmed: 23423739

PLoS One. 2014 Mar 18;9(3):e92083

pubmed: 24642895

Int J Cancer. 2012 Jul 15;131(2):488-96

pubmed: 21866550

Mol Clin Oncol. 2015 May;3(3):649-654

pubmed: 26137282

Int J Mol Epidemiol Genet. 2012;3(1):1-17

pubmed: 22493747

Carcinogenesis. 2003 Mar;24(3):505-9

pubmed: 12663511

J Cancer Res Ther. 2018 Dec;14(Supplement):S1173-S1177

pubmed: 30539866

Biosci Rep. 2018 Jun 21;38(3):

pubmed: 29669843

Biosci Rep. 2019 Dec 20;39(12):

pubmed: 31710080

Clin Cancer Res. 2007 Jun 15;13(12):3753-8

pubmed: 17575242

Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2524-30

pubmed: 16284373

Biochem Genet. 2018 Aug;56(4):375-396

pubmed: 29516319

Carcinogenesis. 2009 May;30(5):785-92

pubmed: 19270000

Zhonghua Nei Ke Za Zhi. 2011 Oct;50(10):859-62

pubmed: 22321329

Cancer. 2012 Feb 1;118(3):594-602

pubmed: 21751184

Carcinogenesis. 2008 Nov;29(11):2112-9

pubmed: 18711149

Lung Cancer. 2011 Aug;73(2):138-46

pubmed: 21195504

Mutagenesis. 2010 Nov;25(6):569-75

pubmed: 20817763

Tumour Biol. 2016 Aug;37(8):10193-207

pubmed: 26831662

Onco Targets Ther. 2016 Nov 14;9:7019-7028

pubmed: 27895494

Clin Respir J. 2018 Feb;12(2):448-458

pubmed: 27460688

Carcinogenesis. 2006 Mar;27(3):560-7

pubmed: 16195237

Carcinogenesis. 2004 Dec;25(12):2433-41

pubmed: 15333465

Biosci Rep. 2018 Dec 14;38(6):

pubmed: 30420492

Anticancer Res. 2010 Jun;30(6):2203-8

pubmed: 20651370

Genetika. 2014 Apr;50(4):481-90

pubmed: 25715450

Carcinogenesis. 2009 Mar;30(3):472-9

pubmed: 19029193

Mutat Res. 2007 Jun 1;619(1-2):68-80

pubmed: 17363013

Medicine (Baltimore). 2018 Jun;97(26):e11276

pubmed: 29953005

Environ Health Perspect. 2007 Aug;115(8):1231-6

pubmed: 17687452

Artif Cells Nanomed Biotechnol. 2020 Dec;48(1):15-27

pubmed: 31852249

Tumour Biol. 2014 Jul;35(7):6607-17

pubmed: 24696258

Mol Biol Rep. 2012 Jun;39(6):6791-9

pubmed: 22314912

Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10):2033-41

pubmed: 17932351

J Cancer Res Clin Oncol. 2008 Feb;134(2):263-70

pubmed: 17653764

J Oral Pathol Med. 2006 Jan;35(1):11-8

pubmed: 16393248

J Am Chem Soc. 2014 Aug 6;136(31):10830-3

pubmed: 25056193

Science. 2015 May 8;348(6235):648-60

pubmed: 25954001

Lung Cancer. 2008 Feb;59(2):171-9

pubmed: 17913280

Cancer Lett. 2005 May 10;222(1):67-74

pubmed: 15837542

Carcinogenesis. 2007 Mar;28(3):665-71

pubmed: 17040931

Mol Biol Rep. 2012 Jan;39(1):527-34

pubmed: 21559836

J Cancer. 2018 Jul 1;9(15):2751-2756

pubmed: 30087717

PLoS Genet. 2012;8(3):e1002555

pubmed: 22396665